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calculated 191.7cGy. The error in film measurement increases from 
1.4cGy to 2.2cGy if a single film is used instead of a 5-film sample. 
Conclusions: Submillimeter point dose measurement with EBT2 film is 
shown to be very accurate. Signal extraction from such a small spatial 
area allows for accurate measurement in small-fields, steep dose 
gradients, and non-flattened beams.  
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Purpose/Objective: An optical fibre sensor for use in radiotherapy 
dosimetry is presented. The sensor is based on a scintillating material 
coated plastic optical fibre (POF), which emits visible light when 
exposed to low level ionising radiation. The incident level of ionising 
radiation can be determined by analysing the observed emission 
spectra. The work presented reports on the design of the sensor and 
the stability of the sensor during measurement of incident x-ray 
energy. Initial testing of the sensor on a Linac is presented, 
demonstrating the suitability of such a sensor for a range of 
radiotherapy dosimetry applications, including the area of small field 
dosimetry. 
Materials and Methods: A 1 metre PMMA (Polymethyl Methacrylate) 
plastic optical fibre of 1mm diameter is prepared.The optical fibre 
cable end was polished, an epoxy resin and hardener mix,containing 
the scintillation material, was then encapsulated around the fibre 
cable end using an injection method and allowed to set. The radiation 
source used was a Siemens Artiste, with a water equivalent phantom 
of varying depths. The sensor was connected to a fluorescent 
spectrometer using a 19 meter long POF cable. The spectrometer and 
a computer for analysing the resultant optical signal were located at 
the control console. The optical fibre coated with a scintillation 
material fluoresces when subjected to ionising radiation. Upon 
scintillation, the low level light permeates the fibre optic cable end 
and the spectrometer placed at the distal end of the POF cable 
measures the received optical signal. The amount of radiation 
incident on the sensor is directly related to the measured intensity of 
the received spectrum at the preselected wavelengths. The 
spectrometer detects and records low level light from the sensor and 
detects any changes in optical intensity levels that are recorded via 
LabVIEW software. 
 
 Results: The optical fibre sensor was initially tested for its response 
to 100MU (Monitor Units,where 1MU = 1cGy when SSD (surface to 
source distance) is 100cm at a depth of Dmax.) at 6MV photon energy 
using a 1.5cm build-up. The peak intensity of the received fluorescent 
signal, at 544nm, was monitored. During irradiation the sensor 
demonstrates a stable response and then returns to its original off 
state when the radiation stops. The sensor was then tested at 
repeated radiation doses of 100MU at 15MV to test for the stability of 
the optical fibre sensor at repeated exposures. 
 
  
Conclusions: The optical fibre sensor was investigated for its response 
to known incident radiation exposure patterns, repeatability and 
stability of measurement. The sensor demonstrated excellent 
response to a wide range of exposure conditions including different 
levels of ionising energy, dose rates and exposure duration. The 
results show that the sensor is capable of realtime, accurate and 
repeatable radiation dose measurements with a maximum variance of 
± 2% from a Linac. 
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Purpose/Objective: Radiochromic films such as Gafchromic EBT or 
EBT2 offer an excellent spatial resolution which is beneficial for dose 
verification in highly conformal radiation therapy such as IMRT or 
proton therapy. Recently, a new generation of these films, EBT3, has 
become available. As composition and thickness of the sensitive layer 
are the same as for the previous EBT2 films, a similar dosimetric 
performance is expected, in particular with respect to the known 
energy dependence of the films. The side orientation dependence, 
which is reported for EBT2 films, has been eliminated in EBT3 films by 
a symmetric layer configuration.  
Materials and Methods: The general EBT3 film characteristics such as 
read-out orientation dependence and post-exposure darkening growth 
are evaluated and compared to EBT2 films. Film response has been 
investigated in clinical photon and proton beams. The energy 
dependence of both, EBT2 and EBT3 films, has been studied for low 
proton energies (<=20MeV) as predominating in the vicinity of the 
Bragg peak but also up to a maximum energy of 200 MeV. 
Results: In general, EBT3 show a comparable performance to EBT2 
films, moreover, orientation dependence with respect to film side is 
completely eliminated in EBT3 films. Response differences of EBT2and 
EBT3 films are of the same order of magnitude as batch-to-batch 
variations observed for EBT2 films. Photon and proton exposure show 
similar response for both generations of EBT films. Depth dose 
measurements show an under-estimation of dose by up to 20 % in the 
Bragg peak region for both types of film.  
Conclusions: EBT3 and its precursor EBT2 have similar dosimetric 
performance and can, thus, be applied to dose verification in IMRT in 
the same way. Dose under-response in the Bragg peak region has to be 
taken into account if films are to be applied for dose verification in 
proton therapy.  
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Purpose/Objective: In the radiotherapy Treatment Planning Systems 
(TPS) various calculation algorithms are used (Pencil Beam 
Convolution PBC, analytical anisotropic algorithm AAA, Monte-Carlo). 
The accuracy of dose calculations has to be verified. Numerous 
phantom types and detectors are proposed to verify the TPS 
calculations by dosimetric measurements. A heterogeneous cubic-
shape phantom has been designed for this purpose within a 
Coordinated Research Project of the IAEA. 
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Materials and Methods: The heterogeneous phantom was developed 
in the frame of IAEA Coordinated Research Project. The phantom 
consists of frame made with polystyrene and bone or lung equivalent 
inhomogeneity slabs. Special inserts allow to position TLD capsules 
within the polystyrene below the bone or lung material and also 
within the lung equivalent material. Additionally, there are inserts 
that allow for positioning the ionization chamber and films in the 
phantom. This enables comparisons of the doses calculated by TPSs 
for specific treatment fields in specified points with the 
measurements performed with various detectors. The comparisons 
were performed for a number of TPS (Eclipse from Varian, XiO, from 
CMS, Oncentra MasterPlan from Nucletron, Panther from Prowess, 
PrecisePlan fromElecta, Pinacle from Philips) and for a number of 
linear accelerators (Varian, Siemens, Elekta) in several radiotherapy 
departments in Poland in the framework of the Quality Assurance 
Audit programme in Poland. 
Results: Seven Polish radiotherapy centers (of 28 in total) were 
audited. Six different TPSs and eleven calculation algorithms were 
examined. Generally, most of the results obtained with TLD and 
ionizing chamber were within 5% tolerance. Differences between 
doses calculated by TPSs and measured with TLD did not exceed 4% 
for bone equivalent and polystyrene materials. Under the lung 
equivalent material, on the beam axis the differences were lower 
than 5% whereas inside the lung material, off the beam axis – in some 
cases were about 7%.  
Differences of doses measured with ionizing chamber under 
polystyrene and bone or lung equivalent materials were lower than 
5%, whereas inside the lung material the difference was 5,2%. 
Conclusions: The comparison of results for calculations and the 
measurements allow for the detection of limitations of TPS calculation 
algorithms. The audits performed with the use of heterogeneous 
phantom seem to be an effective tool for detecting the errors in basic 
data configuration and the TPS performance at the audited 
radiotherapy departments.  
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Purpose/Objective: Recent developments of new therapy techniques 
using small beams, such as stereotactic radiotherapy, require new 
detectors to precisely determine the delivered dose. The dosimeter 
has to be as close as possible to tissue equivalence and exhibit a small 
detection volume compared to the size of the irradiation field, 
because of the lack of lateral electronic equilibrium. Characteristics 
of single crystal diamond (tissue equivalent material Z=6, high 
density) make it an ideal candidate to fulfill most of the small beam 
dosimetry requirements. 
Materials and Methods: We developed single crystal diamond 
dosimeters (SCDDo) with a small detection volume (<0.4 mm3). The 
Monte-Carlo code PENELOPE (parallelized version) was used to 
optimize the encapsulating material and electrodes of our diamond 
detectors, in order to obtain a tissue equivalent detector. Response 
time, stability and repeatability of the detector were tested under 
Co60 source irradiation. SCDDo dose profile, depth dose and output 
factor measurements, were performed for small beams using two 
stereotactic systems: Varian Clinac 2100 C linear accelerator with 
micro MLC m3 and a Novalis TX linear accelerator. These 
measurements were compared to different detectors, both active and 
passive: diode, micro-LiF (TLD), EBT2 radiochromic film, PinPoint 
ionization chamber. 
Results: SCDDo presents an excellent spatial resolution for dose 
profile measurements, due its small detection volume. OFs obtained 
with SCDDo are very satisfactory from 0.6 x 0.6 cm2 to 10 x 10 cm2 
field sizes, compared to PinPoint ionization chamber which 
underestimates OF values in small beam. 
Conclusions: SCDDo respects the small beam dosimetry requirements 
(tissue-equivalence, small detection volume). The absorbed dose 
measurements obtained with this device are very satisfying compared 
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Purpose/Objective: Radiochromic dosimeters are promising within 
radiotherapy due to the ability to measure dose distributions in 3D 
with high resolution. However, the response to irradiation is low 
compared to clinical relevant dose levels. Improvements of the dose 
response may be found through knowledge of the chemical structure 
of the dosimeter. In this study we therefore examined the nanoscale 
structures in a radiochromic dosimeter that was based on a leuco 
malachite green dye and the surfactant sodium dodecylsulfate (SDS) 
suspended in a gelatin matrix.  
Materials and Methods: The original dosimeter formulation 
investigated consisted of 6 % (w/w) gelatin that formed the volume of 
the 3D dosimeter, 50 mM sodium dodecyl sulfate (SDS) was added as 
surfactant, 5 mM trichloroacetic acid as initiator, 0.37 mM leuco 
malachite green (LMG) as active component and 80 mM 
trichloromethane was added to dissolve the LMG. Small-angle x-ray 
scattering was then used to investigate the structures of a range of 
compositions of the dosimeter by omitting different components of 
the dosimeter formulation. 
Results: When omitting gelatin ellipsoidal micelles of SDS were 
formed with a core radius near 15 Å and shell thickness near 7 Å 
(figure 1).Gelatin significantly changed the micelles to a cylindrical 
shape with around three times lower core radius and four times larger 
shell thickness, which indicates that the gelatin is present in the shell 
and the outer part of the core. 
  
Conclusions: It was possible to measure the individual dosimeter 
components effect on the chemical structures of the dosimeter. Using 
knowledge of the chemical structure, it might be possible to construct 
an improved dosimeter with a clinical relevant dose response by 
modifying the chemical composition and thereby the micelle 
structures.  
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Purpose/Objective: To quantify the accuracy of a method to localize 
the sensitive volume of water equivalent in-vivo plastic scintillation 
detectors (PSDs) on Computerized Tomography (CT) images. PSDs 
when inserted in patients cannot be directly visualized on CT images 
